The backing is there......
“with up to $700,000 for product development, marketing and distribution. The Reg A will be funded by institutional and accredited investors in an equity based, non-convertible debt offering”
Fort Lee, NJ., (Uptick Newswire – August 28, 2017) – Herborium Group, Inc. (OTCMKTS:HBRM), www.Herborium.com, a Botanical Therapeutics® Company and the provider of unique all botanical medicinal products (Botanical Therapeutics®) announced today that it has officially committed to expanding into the hemp based products market. This expansion is backed by a Reg A Offering that will fund the Company’s already established, as well as new projects monetization, with up to $700,000 for product development, marketing and distribution. The Reg A will be funded by institutional and accredited investors in an equity based, non-convertible debt offering.
Herborium’s hemp and CBD based expansion will focus on partnerships with selected domestic and international hemp, CBD manufacturers who have proven, ready for market products but lack the marketing know-how and capabilities represented by Herborium. Additionally, the Company will work with hemp and CBD extractors to develop proprietary products for Herborium under its own soon to be announced brand. The Company has been conducting due diligence on several hemp, CBD companies and expects to move forward with one or more products once due diligence is complete.
Herborium’s unique know how of the herbal science and industry as well as its marketing expertise and resources make the Company an attractive partner in the growing hemp CBD market. Herborium intends to leverage this expertise and resources to continue its growth and expansion in the global herbal medicine and dermaceuticals market which is projected to reach $115 billion by 2020.
